PDCD1 and neoplasm: In summary, our single-cell analysis demonstrates that combining DRP-104 with anti-PD1 may alter the functionality and transcriptional state of Keap1 mutant tumor–infiltrating CD4 and CD8 T cell populations, driving them from an exhausted program toward a more functional effector/memory state.